Inventor · disambiguated record
Johannes Antonius Gerardus Van Strijp
Also filed as: VAN STRIJP JOHANNES A G · VAN STRIJP JOHANNES ANTONIUS G · VAN STRIJP JOHANNES ANTONIUS GERARDUS
4 granted patents·7 pending applications·50 citations·filing 1997–2010
75Inventor score
Files withALLIGATOR BIOSCIENCE AB3UMC UTRECHT HOLDING BV2DE HAAS CARLA J C1FUREBRING CHRISTINA1UNIV UTRECHT1
Top patents by PatentIndex Score
11 records- 0179US7388078B2Nucleic acids encoding polypeptides having chips activityALLIGATOR BIOSCIENCE AB·Filed 2006·Granted Jun 17, 2008·5 cites·5 claims
- 0276US6365570B1Pharmaceutical and diagnostic use of Serum Amyloid P componentUNIV UTRECHT·Filed 1997·Granted Apr 2, 2002·36 cites·6 claims
- 0373US7081513B2Nucleic acids encoding (poly) peptides having chips activityALLIGATOR BIOSCIENCE AB·Filed 2001·Granted Jul 25, 2006·8 cites·2 claims
- 0457US8173774B2Polypeptides and use thereofFUREBRING CHRISTINA·Filed 2007·Granted May 8, 2012·1 cites·34 claims
- 0551US2010104603A1Use of staphylococcal superantigen-like protein 5 (ssl5) in medicineDE HAAS CARLA J C·Filed 2007·Application pending·0 cites
- 0650US2008242605A1Chemotaxis-inhibiting protein of staphylococcus (chips) and its useALLIGATOR BIOSCIENCE AB·Filed 2007·Application pending·0 cites
- 0741US2009264359A1Fplr-1 inhibitors for use in diseases involving amyloid-induced inflammatory events (flipr and flipr-like) and immunecomplex-mediated diseasesVAN KESSEL CORNELIS PETRUS MARIA·Filed 2007·Application pending·0 cites
- 0841US2009202437A1Therapeutic Use of Lpi, a Staphylococcal Lectin Pathway Inhibitor in Inflammatory diseasesVAN WAMEL WILLEM JAN BASTIAAN·Filed 2004·Application pending·0 cites
- 0939US2009246175A1Therapeutic use of scin, a staphylococcal complement inhibitor in inflammatory diseasesUMC UTRECHT HOLDING BV·Filed 2006·Application pending·0 cites
- 1035US2008233137A1Compounds that Block the C5a Receptor and Their Use in TherapyVAN STRIJP JOHANNES ANTONIUS GERARDUS·Filed 2005·Application pending·0 cites
- 1133US2011118194A1Therapeutic Use of LPI, a Staphylococcal Lectin Pathway Inhibitor in Inflammatory DiseasesUMC UTRECHT HOLDING BV·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →